| Antitumor activity of small double-stranded oligodeoxynucleotides targeting telomerase RNA in malignant melanoma cells. | |
| | |
MedLine Citation:
|
PMID: 19441892 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Human telomerase RNA (hTR) is an intrinsic component of telomerase enzyme. Small interfering RNAs (siRNAs) and single-stranded antisense oligonucleotides have been used previously for silencing of the hTR. The objective of this study was to investigate the effect of partially double-stranded oligodeoxynucleotides (ODNs), in vitro and in vivo in comparison to single-stranded antisense ODNs and siRNAs. ODNs were designed on the basis of structural properties of an ODN from previous studies on HIV, to target the hTR in the human cervical carcinoma HeLa cell line and mouse telomerase RNA (mTR) in the murine metastatic melanoma B16-F10 cell line, respectively. Our results indicate that ODNs were able to inhibit the hTR by 68% and the mTR by 81% in the respective cell lines. This correlated with ODN-mediated rapid inhibition of cell proliferation and induction of apoptosis excluding slow effects on telomerase function. The inhibition of the hTR was decreased by knock-down of the cellular RNases H suggesting their contribution. Furthermore, we showed a reduction in numbers of metastases by 70% after intravenous administration of ODN-transfected B16-F10 cells in C57BL/6 mice. Our study demonstrates the potential utility of these hairpin-loop-structured ODNs as a different group of nucleic acids for telomerase-based antiproliferative strategies. |
| | |
Authors:
|
Faiza Noreen; Jochen Heinrich; Karin Moelling |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Oligonucleotides Volume: 19 ISSN: 1557-8526 ISO Abbreviation: Oligonucleotides Publication Date: 2009 Jun |
Date Detail:
|
Created Date: 2009-05-20 Completed Date: 2009-07-31 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101188415 Medline TA: Oligonucleotides Country: United States |
Other Details:
|
Languages: eng Pagination: 169-78 Citation Subset: IM |
Affiliation:
|
Institute of Medical Virology, University of Zurich, Zurich, Switzerland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Apoptosis Cell Line, Tumor Cell Proliferation Cell Survival Female Gene Knockdown Techniques Hela Cells Humans Lung Neoplasms / prevention & control*, secondary Melanoma / pathology, therapy* Mice Mice, Inbred C57BL Oligodeoxyribonucleotides / administration & dosage, genetics, therapeutic use* RNA / antagonists & inhibitors* Telomerase / antagonists & inhibitors* Transfection |
| Chemical | |
Reg. No./Substance:
|
0/Oligodeoxyribonucleotides; 0/telomerase RNA; 63231-63-0/RNA; EC 2.7.7.49/Telomerase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Optimized Basic Conditions Are Essential for Successful siRNA Transfection into Primary Endothelial ...
Next Document: Naked siLNA-mediated gene silencing of lung bronchoepithelium EGFP expression after intravenous admi...